Characterization of recombinant human coagulation factor XFriuli

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 313-317

  Kim, D J ^a   Girolami, A ^b   James, H L ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ASPARTIC ACID DERIVATIVE; BLOOD CLOTTING FACTOR 10; COMPLEMENTARY DNA; PROLINE; RECOMBINANT PROTEIN; SERINE;

AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; GEL ELECTROPHORESIS; HYDROGEN BOND; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS;

1-CARBOXYGLUTAMIC ACID; ASPARTIC ACID; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA, COMPLEMENTARY; ENZYME ACTIVATION; FACTOR X; HEMORRHAGIC DISORDERS; HUMANS; HYDROGEN BONDING; KIDNEY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROLINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SERINE; TRANSFECTION;

EID: 0029990233     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650267     Document Type: Article

References (32)

1. Jackson CM. Factor X. In: Progress in Hemostasis and Thrombosis, Vol 7. Spaet TH. ed. Grune & Stratton, Orlando, FL 1984; pp 55-109.
2. Pfeiffer RA, Ott R, Gilgenkrantz S, Alexandre P. Deficiency of coagulation factors VII and X associated with deletions of a chromosome 13(q34). Evidence from two cases with 46,XY, t(13;y)(q11;q34). Hum Genet 1982; 62: 358-60.
3. Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 1986; 25: 5098-102.
4. Fujikawa K, Titani K, Davie EW. Activation of bovine factor X (Stuart factor): conversion of activation of factor Xaα to Xaβ. Proc Natl Acad Sci USA 1975; 72: 3359-63.
5. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
6. Girolami A, Molaro G, Lazzarin M, Scarpa R. Una nuova coagulopatia emorragica congenita dovuta alla presenza di un fattore X abnorme. Studio preliminare. Minerva med, Roma 1969; 60: 4939-49.
7. Girolami A, Brunetti A, Bareggi G, Cella S. Abnormal factor X (Factor X Friuli) coagulation disorder. The heterozygote population. Acta Haemat 1974; 51: 40-50.
8. Fair DS, Revak DJ, Hubbard JG, Girolami A. Isolation and characterization of the factor X Friuli variant. Blood 1989; 73: 2108-16.
9. James HL, Girolami A, Fair DS. Molecular defect in coagulation factor X Fnuli results from a substitution of serine for proline at position 343. Blood 1991; 77: 317-23.
10. Beaucage SI, Caruthers MH. Deoxynucleoside phosphoramidites - A new class of key intermediates for deoxypolynucleotide synthesis. Tetrahed Lett 1981; 22: 1859-62.
11. Kim DJ, James HL. Expression of human factor X with normal biological activity in human embryonic kidney cells. Biotech Lett 1994; 16: 549-54.
12. Nelson RM, Long GL. A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal Biochem 1989; 180: 147-51.
13. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1991.
14. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-52.
15. Fair DS, Plow EF, Edgington TS. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest 1979; 64: 884-94.
16. Chattopadyay A, Fair DS. Molecular recognition in the activation of human blood coagulation factor X. J Biol Chem 1989; 264: 11035-43.
17. Wenarchee I and II; compound heterozygosity involving two variant proteins. Biochim Biophys Acta 1995; 1271: 327-34.
18. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035-8.
19. Przysiecki CT, Staggers JE, Ramit HG, Musson, DG, Stern AM, Bennett CD, Friedman PA. Occurrence of β-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains. Proc Natl Acad Sci USA 1987; 84: 7856-60.
20. Padmanabahn K, Padmanabann KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W Structure of human Des(1-45) factor Xa at 2.2 Å resolution. J Mol Biol 1993; 232: 947-66.
21. Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor) and protein S. Biochemistry 1977; 16: 698-706.
22. James HL. Factor X. In: Haemostasia and Thrombosis, Vol 1. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Churchill Livingstone, Edinburgh 1994; pp 439-64.
23. Toomey JR, Smith KJ, Stafford DW. Localization of the human tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-202.
24. val-397. J Biol Chem 1991; 266: 15213-20.
25. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-34.
26. Walls JD, Berg DT, Yan SB, Grinnell BW. Amplification of multicistronic plasmids in the human 293 cell line and secretion of correctly processed recombinant protein C. Gene 1989; 81: 139-49.
27. 2 to tyrosine 18 in the activation peptide. J Biol Chem 1986; 261: 4008-14.
28. Kraut J. Chymotrypsinogen: X-ray structure. In: The Enzymes, vol III. Boyer PD, ed. Academic Press, San Diego, CA 1983; pp 165-83.
29. 86 in phage T4 lysozyme extend an α-helix but do not alter protein stability. Science 1988; 239: 631-5.
30. Chattopadhyay A, James HL, Fair DS Molecular recognition sites on factor X which participate in the prothrombinase complex. J Biol Chem 1992; 267: 12323-9.
31. Fernlund P, Stenflo J. β-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem 1983; 258: 12509-12.
32. Fung MR. Molecular genetics of blood coagulation factor X. PhD dissertation. University of British Columbia, Vancouver, Canada 1988.